AVITA Medical, Inc. (RCEL)

AVITA Medical Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for AVITA Medical stock have an average target of 17.25, with a low estimate of 12 and a high estimate of 22. The average target predicts an increase of 76.92% from the current stock price of 9.75.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$12	$17.25	$21	$22
Change	+23.08%	+76.92%	+115.38%	+125.64%

Analyst Ratings

The average analyst rating for AVITA Medical stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Sep '24	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25
Strong Buy	0	0	0	1	2	2
Buy	1	1	1	1	1	1
Hold	2	2	2	2	2	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	3	3	3	4	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $25 → $22	Strong Buy	Maintains	$25 → $22	+125.64%	Feb 20, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $25	Strong Buy	Maintains	$25	+156.41%	Feb 14, 2025
Brooks O'Neil Lake Street	Lake Street	Strong Buy Maintains $20 → $14	Strong Buy	Maintains	$20 → $14	+43.59%	Jan 8, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $25	Strong Buy	Maintains	$25	+156.41%	Jan 8, 2025
Ross Osborn Cantor Fitzgerald	Cantor Fitzgerald	Buy Reiterates $21	Buy	Reiterates	$21	+115.38%	Dec 24, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

104.16M

Increased by 62.11%

from 64.25M

Revenue Next Year

136.65M

Increased by 31.19%

from 104.16M

EPS This Year

-0.85

from -2.39

EPS Next Year

-0.27

from -0.85

Fiscal Year	FY 2021	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Jun 30, 2021	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	29.23M	33.03M	34.42M	50.14M	64.25M	104.16M	136.65M	231.73M
Revenue Growth	104.95%	12.98%	4.23%	45.68%	28.14%	62.11%	31.19%	69.58%
EPS	-1.17	-1.03	-1.07	-1.40	-2.39	-0.85	-0.27	0.20
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	48.33
No. Analysts	-	-	-	-	-	10	8	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	111.5M	162.8M	322.5M
Avg	104.2M	136.7M	231.7M
Low	97.9M	121.4M	144.3M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	73.5%	56.3%	136.0%
Avg	62.1%	31.2%	69.6%
Low	52.4%	16.6%	5.6%

EPS Forecast

EPS	2025	2026	2027	2028	2029
High	-0.19	-0.04	0.21
Avg	-0.85	-0.27	0.20
Low	-1.75	-0.86	0.19

EPS Growth

EPS Growth	2025	2026	2027	2028	2029
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.